2 Americans, 1 Israeli win Nobel chemistry prize

Oct 07, 2009 By KARL RITTER and MATT MOORE , Associated Press Writers
Joint winner of the 2009 chemistry Nobel Prize Venkatraman Ramakrishnan, sits in his lab at the Medical Research Council Lab in Cambridge, England, Wednesday, Oct. 7, 2009. Ramakrishnan with Thomas Steitz and Israeli Ada Yonath won the 2009 Nobel Prize in chemistry on Wednesday for mapping ribosomes, one of the cell's most complex components, at the atomic level.The Royal Swedish Academy of Sciences said their work has been fundamental to the scientific understanding of life and has helped researchers develop antibiotics cures for various diseases. (AP Photo/Alastair Grant)

(AP) -- Two Americans and an Israeli scientist won the 2009 Nobel Prize in chemistry on Wednesday for atom-by-atom mapping of the protein-making factories within cells - a feat that has spurred the development of antibiotics.

The Royal Swedish Academy of Sciences said Venkatraman Ramakrishnan, Thomas Steitz and Israeli Ada Yonath's work on ribosomes has been fundamental to the scientific understanding of life. They will split the 10 million (US$1.4 million award).

Yonath, 70, is the fourth woman to win the Nobel prize and the first since 1964, when Dorothy Crowfoot Hodgkin of Britain received the award.

"I'm really, really happy," Yonath said. "I thought it was wonderful when the discovery came. It was a series of discoveries. ... We still don't know every, everything, but we progressed a lot."

Ribosomes are crucial to life because they produce the proteins that control the chemistry of plants, animals and humans. Working separately, the three laureates used a method called to pinpoint the positions of the hundreds of thousands of atoms that make up the ribosome.

Their three-dimensional models show how different antibiotics bind to ribosomes - an understanding that has helped other researchers develop to fight bacterial infections.

"These models are now used by scientists in order to develop new antibiotics, directly assisting the saving of lives and decreasing humanity's suffering," the academy said in its announcement.

Many of today's antibiotics cure diseases by blocking the function of bacterial ribosomes, the citation said. "Without functional ribosomes, bacteria cannot survive. This is why ribosomes are such an important target for new ."

The work was published in 2000. While many Nobel winners are honored for joint work, this year's chemistry winners were competing with each other, award committee member Mans Ehrenberg said.

Their work builds on Charles Darwin's theory of evolution and, more directly, on the work done by James Watson, Francis Crick and Maurice Wilkins, who won the 1962 in medicine for mapping DNA's double helix, the citation said.

In 2006, Roger D. Kornberg won the Nobel Prize in chemistry for X-ray structures that showed how information is copied to messenger RNA molecules, which carry information from DNA to the ribosomes.

"Now, one of the last pieces of the puzzles has been added - understanding how proteins are made," said Professor Gunnar von Heijne of the Swedish Academy of Sciences, the chairman of the Nobel Committee for Chemistry."

Thomas Lane, president of the American Chemical Society, said the award was an example of how chemistry can improve people's lives.

"For me it's another example where chemistry is the central science for addressing some of these very big issues," he said. "You hear words like 'ribosome' and 'bacteria,' and you tend to think biology when in fact it's chemistry at work."

Indian-born Ramakrishnan, 57, is the senior scientist and group leader at the Structural Studies Division of the MRC Laboratory of Molecular Biology in Cambridge, England.

Ramakrishnan, who received a doctorate in physics from Ohio University in 1976, said that he wasn't convinced when he got the morning phone call from the academy.

"Well, you know, I thought it was an elaborate joke. I have friends who play practical jokes," Ramakrishnan told The Associated Press by telephone from his lab in Cambridge. "I complimented him on his Swedish accent."

Ramakrishnan described his work on ribosomes as an attempt to understand "this large molecular machine that takes information from genes and uses it to stitch together protein."

He said he and others had been using X-ray crystallography to build an "atomic picture of this enormous machine."

"Now we can start figure out how it does this complicated process," he said.

Steitz, a 69-year-old born in Milwaukee who was graduated by Lawrence University in 1962 and received a doctorate from Harvard in 1966, is a professor of molecular biophysics and biochemistry at Yale University and is an investigator with the Howard Hughes Medical Institute.

Steitz told the AP that the research cited by the academy "was done in parallel, but independently" and said he has known Ramakrishnan since the 1980s. He has met Yonath before, too.

"Well, we were all trying to get to the same goal independently and wanted to get there as fast as possible. I didn't feel it was a personal competition, but it was a bit of a race," he said of the effort. "We were all taking separate approaches."

Yonath is a professor of structural biology at the Weizmann Institute of Science in Rehovot, Israel, and the ninth Israeli to win a Nobel prize. Born in Jerusalem in 1939 to an impoverished Jewish family, she gained her undergraduate degree in chemistry and her master's degree in biochemistry from Hebrew University of Jerusalem in the 1960s. She earned her doctorate at Weizmann.

She told Israel Radio she didn't think her gender played a role in the decision.

"It's true that a woman hasn't won since 1964. But I don't know what that means - does it mean that I'm the best woman since then? I don't think that gender played a role here," she said.

She had to end the interview abruptly because Israeli President Shimon Peres, a Nobel Peace prize laureate, was on the other line.

Alfred Nobel, a Swedish industrialist who invented dynamite, established the Nobel Prizes in his will in 1895. The first awards were handed out six years later.

Each prize comes with a 10 million kronor ($1.4 million) purse, a diploma, a gold medal and an invitation to the prize ceremony in Stockholm on Dec. 10. The Peace Prize is handed out in Oslo.

On Monday, three American scientists shared the Nobel Prize in medicine for discovering a key mechanism in the genetic operations of cells, an insight that has inspired new lines of research into cancer.

The physics prize on Tuesday was split between a Hong Kong-based scientist who helped develop fiber-optic cable and two Canadian and American researchers who invented the "eye" in digital cameras - technology that has revolutionized communications and science.

The literature and peace prize winners will be announced later this week and the economics announcement is set for Monday.

On the Net: http://www.nobelprize.org

Found in translation: the ribosome

The ribosome, the focus of this year's Nobel Chemistry Prize, is a cellular marvel, making the myriad proteins which comprise and sustain life.

The ribosome makes them by translating code from DNA, using sequences from the famous double-helix molecule to assemble proteins through building blocks called amino acids.

It does the trick thanks to two dogsbody molecules of RNA, which is a single-strand version of DNA.

One of them is messenger RNA (mRNA), which floats out from the cell nucleus, carrying to the ribosome the instructions, copied from DNA, for making the specific protein.

The ribosome, which under the microscope looks like a jumble of coils, works its way along this piece of code, using it as a template.

Every three base pairs, or rungs, in the code correspond to the recipe for an amino acid, which is hauled to the ribosome by matching molecules of transfer RNA (tRNA).

These amino acids are introduced into the ribosome, which exudes the protein block by block, until the completed molecule separates from the machine and eventually exits the cell.

Without the ribosome, there would be no life, or certainly no life at a complex scale. The body has tens of thousands of proteins, ranging from cells which comprise specific tissues or immune defences to signal molecules and enzymes.

"An understanding of the ribosome's innermost workings is important for a scientific understanding of life," the Nobel jury said, in honouring Venkatraman Ramakrishnan and Thomas Steitz of the United States and Ada Yonath of Israel.

The trio share the coveted award for X-ray crystallography that laid bare the ribosome and helped explain its function.

Their feat not only explains a fundamental mechanism, but also opens the way to new-generation antibiotics -- drugs that inhibit the ribosome machinery in bacteria.

Around 90,000 patients in the United States die from bacterial infections each year, or more than six times the toll of 20 years ago, and most of the deaths are attributable, at least in part, to resistance to antibiotics, the Nobel committee said.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
(c) 2009 AFP

Explore further: Major step forward in understanding of viruses as scientists unlock exact structure of Hep A virus

add to favorites email to friend print save as pdf

Related Stories

Israeli woman potential Nobel chemistry winner

Oct 07, 2009

(AP) -- If Nobel judges are looking to improve the balance of women winning the chemistry prize, Israeli scientist Ada Yonath could be a strong candidate when the award is announced Wednesday.

Stem cell pioneers among Nobel Prize candidates

Oct 04, 2009

(AP) -- Two Canadian scientists whose discovery of stem cells has paved the way for controversial research could be candidates for the 2009 Nobel Prize in medicine, the winners of which will be announced Monday.

Recommended for you

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

omatumr
3 / 5 (1) Oct 08, 2009
Congratulations!

It is great to see the Nobel Prize given for first-class work.

With kind regards,
Oliver K. Manuel